France
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
136.49%
|
Dec. 31, 2023 | USD 2.16 | 6.70% |
|
France |
|
2 |
128.03%
|
Dec. 31, 2023 | USD 12.26 | 1.46% |
|
France |
|
3 |
120.46%
|
Dec. 31, 2023 | USD 3.05 | 0.95% |
|
France |
|
4 |
100.13%
|
Dec. 31, 2023 | USD 2.29 | 4.37% |
|
France |
|
5 |
100.00%
|
Dec. 31, 2023 | USD 1.82 | 1.18% |
|
France |
|
6 |
100.00%
|
Dec. 31, 2023 | USD 4.64 | -14.23% |
|
France |
|
7 |
100.00%
|
Dec. 31, 2023 | USD 6.44 | -3.56% |
|
France |
|
8 |
100.00%
|
Dec. 31, 2023 | USD 6.91 | 0.46% |
|
France |
|
9 |
98.81%
|
Dec. 31, 2023 | USD 3.40 | -0.30% |
|
France |
|
10 |
97.23%
|
Dec. 31, 2023 | USD 6.25 | -0.54% |
|
France |
|
11 |
95.39%
|
Dec. 31, 2023 | USD 4.25 | 1.59% |
|
France |
|
12 |
93.80%
|
Dec. 31, 2023 | USD 3.97 | 0.60% |
|
France |
|
13 |
82.72%
|
Dec. 31, 2023 | USD 122.64 | 0.35% |
|
France |
|
14 |
78.75%
|
June 30, 2024 | USD 12.99 | 0.21% |
|
France |
|
15 |
76.68%
|
March 31, 2024 | USD 16.86 | 0.98% |
|
France |
|
16 |
74.28%
|
Dec. 31, 2023 | USD 8.53 | 3.61% |
|
France |
|
17 |
74.01%
|
Dec. 31, 2023 | USD 27.36 | -1.07% |
|
France |
|
18 |
72.60%
|
Dec. 31, 2023 | USD 27.83 | 2.50% |
|
France |
|
19 |
69.07%
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
20 |
64.42%
|
Dec. 31, 2023 | USD 6.08 | 1.81% |
|
France |
|
21 |
63.71%
|
June 30, 2024 | USD 5.46 | 0.23% |
|
France |
|
22 |
62.02%
|
Dec. 31, 2023 | USD 10.08 | 4.45% |
|
France |
|
23 |
57.03%
|
Dec. 31, 2023 | USD 1.53 | 0.60% |
|
France |
|
24 |
56.81%
|
Dec. 31, 2023 | USD 1.50 | -9.33% |
|
France |
|
25 |
55.99%
|
Dec. 31, 2023 | USD 110.89 | -1.59% |
|
France |
|
26 |
55.05%
|
Dec. 31, 2023 | USD 71.52 | -1.80% |
|
France |
|
27 |
52.84%
|
Dec. 31, 2023 | USD 2.27 | 11.78% |
|
France |
|
28 |
45.85%
|
Dec. 31, 2023 | USD 20.08 K | 0.04% |
|
France |
|
29 |
45.26%
|
Dec. 31, 2023 | USD 2.05 | -2.81% |
|
France |
|
30 |
44.44%
|
Dec. 31, 2023 | USD 208.18 | -0.28% |
|
France |
|
31 |
44.00%
|
Dec. 31, 2023 | USD 26.07 | 0.60% |
|
France |
|
32 |
41.50%
|
Dec. 31, 2023 | USD 13.50 | -2.38% |
|
France |
|
33 |
40.40%
|
Dec. 31, 2023 | USD 2.02 | -2.42% |
|
France |
|
34 |
35.09%
|
June 30, 2024 | USD 3.36 | -0.01% |
|
France |
|
35 |
34.37%
|
Dec. 31, 2023 | USD 2.16 | -2.19% |
|
France |
|
36 |
32.75%
|
Dec. 31, 2023 | USD 23.70 | 2.39% |
|
France |
|
37 |
32.21%
|
Dec. 31, 2023 | USD 0.68 | -1.49% |
|
France |
|
38 |
31.79%
|
Dec. 31, 2023 | USD 39.47 | -3.91% |
|
France |
|
39 |
31.41%
|
Dec. 31, 2023 | USD 1.91 | 0.06% |
|
France |
|
40 |
16.15%
|
Dec. 31, 2023 | USD 3.26 | 2.55% |
|
France |
|
41 |
13.32%
|
Dec. 31, 2023 | USD 1.29 | -1.75% |
|
France |
|
42 |
12.62%
|
Dec. 31, 2023 | USD 5.49 | 1.56% |
|
France |
|
43 |
9.54%
|
Dec. 31, 2023 | USD 4.54 | 0.83% |
|
France |
|
44 |
8.84%
|
June 30, 2024 | USD 23.39 | -1.14% |
|
France |
|
45 |
8.52%
|
Dec. 31, 2023 | USD 1.95 | -2.23% |
|
France |
|
46 |
5.50%
|
Dec. 31, 2023 | USD 0.96 | -6.39% |
|
France |
|
47 |
2.38%
|
Dec. 31, 2023 | USD 1.74 | -2.29% |
|
France |
|
48 |
-7.94%
|
Dec. 31, 2023 | USD 1.88 | -0.49% |
|
France |
|
49 |
-98.04%
|
Dec. 31, 2023 | USD 1.42 | -0.83% |
|
France |
|
50 |
-4,231.03%
|
Dec. 31, 2023 | USD 2.22 | -0.32% |
|
France |
The Health Care company in France with the highest Gross Profit Margin is Aelis Farma SA (Paris Stock Exchange: AELIS.PA) at 136.49%.
The Health Care company in France with the lowest Gross Profit Margin is Crossject Société Anonyme (Paris Stock Exchange: ALCJ.PA) at -4,231.03%.
The top 10 Health Care companies in France by Gross Profit Margin are Aelis Farma SA, Plant Advanced Technologies SA, Nanobiotix S.A., Inventiva S.A., PHAXIAM Therapeutics S.A., DBV Technologies S.A., Carbios SAS, OSE Immunotherapeutics SA, Genfit S.A. and ABIVAX Société Anonyme.
The bottom 10 Health Care companies in France by Gross Profit Margin are Crossject Société Anonyme, Affluent Medical SA, Innate Pharma S.A., Cellectis S.A., Neovacs S.A., AFYREN SAS, Bastide Le Confort Médical SA, Euromedis Groupe, EMEIS and ABIONYX Pharma SA.